Forecast 2018 – 2025 | Cancer Drug Industry By Top Key Players (Roche Holdings Inc., Johnson & Johnson, Novartis AG, Celgene, etc.) By Application (Gastrointestinal cancer, Blood cancer, Prostate cancer) By Products & Services (Immunotherapy, Hormonal therapy, Targeted therapy) - Global Opportunity and Current Growth Analysis


Global Cancer Drug Industry was valued at USD 73.40 Billion in the year 2017. Global Cancer Drug Industry is further estimated to grow at a CAGR of 7.98% from 2018 to 2025 to reach USD 135.71 Billion by the year 2025. North America region holds the highest Industry share in 2017 with APAC region is considered as the fastest growing Industry in the forecasted period. At a country level, the U.S is the biggest Industry in 2017 and it is projected to grow at a gradual pace in the coming years.

Global Cancer Drug Industry Share By 2025

The major market players in Cancer Drug Industry are Roche Holdings Inc., Johnson & Johnson, Novartis AG, Celgene, Eli Lilly and Company, Pfizer, Celgene Corporation, Sanofi, Merck & Co., Amgen Inc. (Other 13 companies detailed information is provided in research report). Roche Diagnostics holds the substantial Industry share because of its better global presence both at production and at an operational level. Rising research and development expenses to cater changing demand of end users, similarly, growth strategies such as acquisition, merger, and expansion of the distribution network were few techniques adopted by most of Tier 1 and Tier 2 manufacturers in recent years.
SWOT Analysis of Cancer Drugs Industry

            Growing incidence and pervasiveness of various types of cancer
            Academic alliances and partnerships

            Side-effects of anti-cancer drug therapy
            The high cost of drug development and a threat of failure
            Scientific advancements in treatment methods
            Increasing focus on personalized Anti-cancer medicine

            Patent Cliff
The Immunotherapy segment in the global Cancer Drug Industry is expected to hold the highest Industry share during the forecast period. The growth can be attributed to growing areas within oncology R&D, high efficacy and fewer side effects and unique molecular level targeting. On the other hand, Blood Cancer by the application is expected to grow at the highest CAGR during the year 2018-2025. Majorly due to growing number of blood cancer patient and the high cost of drugs used for the treatment of blood cancer.

By Application
Gastrointestinal cancer
Blood cancer    
Prostate cancer
Skin cancer      
Respiratory/lung cancer
Breast cancer  
Other types of cancers

By Products & Services
Immunotherapy (biologics therapy)       
Hormonal therapy        
Targeted therapy         
By Region

North America

  • USA
  • Canada


• Germany

• U.K.

• France

• Italy

• Rest of Europe


• China

• India

• Japan

• Rest of Asia-Pacific


• Latin America

             • Middle East & Africa

License Type

Find About Us

Contact Us

USA Address

7309 Woodward Ave, Apt 107, Woodridge, Illinois, USA, 60517

Operational & Marketing Center

Global Reports Store Pune (India) Manjari(bk), Hadapsar, Pune 412307


Copyright © 2020 Global Reports Store All rights reserved.